As of 2025-06-13, the Fair Value of Cara Therapeutics Inc (CARA) is -77.53 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.32 USD, the upside of Cara Therapeutics Inc is -1,557.42%.
With the market price of 5.32 USD and our fair value calculation, Cara Therapeutics Inc (CARA) is not a good investment. Investing in CARA stocks now will result in a potential loss of 1,557.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 8.40 | -88.40 | -85.50 | -118.51 | -70.87 | -70.98 |
| YoY growth | 107.89% | -1,152.38% | 3.28% | -38.61% | 40.20% | -207.92% |
| Market Cap (mil) | 24.31 |
| P/E | |
| Forward P/E |
| EPS | -15.51 |
| Avg earnings growth rate | -207.92% |
| TTM earnings | -70.87 |